Recent trends in use of nonbiologic DMARDs and evaluation of their continuation rates in single and dual combination therapies in rheumatoid arthritis patients in Japan

Michihiro Ogasawara,Michiaki Kageyama,Makio Kusaoi,Shin Onuma,Takayuki Kon,Fumio Sekiya,Kaoru Sugimoto,Ran Matsudaira,Masakazu Matsushita,Kurisu Tada,Kazuo Kempe,Ken Yamaji,Naoto Tamura,Yoshinari Takasaki

Recent trends in use of nonbiologic DMARDs and evaluation of their continuation rates in single and dual combination therapies in rheumatoid arthritis patients in Japan

2012

Michihiro Ogasawara
Michiaki Kageyama
Makio Kusaoi
Shin Onuma
Takayuki Kon
Fumio Sekiya
Kaoru Sugimoto
Ran Matsudaira
Masakazu Matsushita
Kurisu Tada
Kazuo Kempe
Ken Yamaji
Naoto Tamura
Yoshinari Takasaki

Objective We aim to examine changes in usage of nonbiologic, disease-modifying antirheumatic drugs (DMARDs) and evaluate their continuation rates in Japan.

Keywords:

Rheumatoid arthritis
Antirheumatic drugs
Physical therapy
Combination therapy
Medicine
Rheumatology
treatment history
Internal medicine
continuation rate
Bucillamine
Methotrexate
disease activity

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations